Recurrent catatonia in a patient with bipolar disorder and polycythemia: A case report
We report the diagnostic and management challenges encountered in a case of a 57-year-old male patient with bipolar I disorder and comorbid polycythemia secondary to obstructive sleep apnea, who was treated in our inpatient psychiatric unit for suicidal ideation and recurrent catatonia. He was found to have catatonia with a Bush–Francis Catatonia Rating Scale score of 18. He subsequently exhibited a positive response to the lorazepam challenge test. Before discharge, his daily lorazepam dose was titrated to 6 mg, which led to resolution of catatonic symptoms, and was tapered to discontinuation. During the second hospitalization, the patient’s catatonia returned, but due to lorazepam-induced bradycardia, he refrained from taking more than 1 mg of the medication. Divalproex sodium and memantine were initiated as off-label catatonic treatment plus lurasidone for bipolar depression. The patient was also found to have a positive antinuclear antibody titer (1:160). The hemato-immunological abnormalities present in our patient complicated his catatonic condition, underscoring the need to explore medical and neuropsychiatric catatonic factors for accurate diagnosis of this neuropsychiatric syndrome.
- Brar K, Kaushik SS, Lippmann S. Catatonia update. Prim Care Companion CNS Disord. 2017;19(5):16br02023. doi: 10.4088/PCC.16br02023
- Walther S, Stegmayer K, Wilson JE, Heckers S. Structure and neural mechanisms of catatonia. Lancet Psychiatry. 2019;6(7):610-619. doi: 10.1016/S2215-0366(18)30474-7
- Rogers JP, Pollak TA, Blackman G, David AS. Catatonia and the immune system: A review. Lancet Psychiatry. 2019;6(7):620-630. doi: 10.1016/S2215-0366(19)30190-7
- Peralta V, Cuesta MJ, Serrano JF, Mata I. The Kahlbaum syndrome: A study of its clinical validity, nosological status, and relationship with schizophrenia and mood disorder. Compr Psychiatry. 1997;38(1):61-67. doi: 10.1016/s0010-440x(97)90055-9
- Rasmussen SA, Mazurek MF, Rosebush PI. Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry. 2016;6(4):391-398. doi: 10.5498/wjp.v6.i4.391
- Hirjak D, Foucher JR, Ams M, et al. The origins of catatonia-systematic review of historical texts between 1800 and 1900. Schizophr Res. 2024;263:6-17. doi: 10.1016/j.schres.2022.06.003
- Fink M, Shorter E, Taylor MA. Catatonia is not schizophrenia: Kraepelin’s error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull. 2010;36(2):314-320. doi: 10.1093/schbul/sbp059
- Francis A, Fink M, Appiani F, et al. Catatonia in diagnostic and statistical manual of mental disorders, fifth edition. J ECT. 2010;26(4):246-247. doi: 10.1097/YCT.0b013e3181fe28bd
- Denysenko L, Sica N, Penders TM, et al. Catatonia in the medically ill: Etiology, diagnosis, and treatment. The academy of consultation-liaison psychiatry evidence-based medicine subcommittee monograph. Ann Clin Psychiatry. 2018;30(2):140-155.
- Beach SR, Gomez-Bernal F, Huffman JC, Fricchione GL. Alternative treatment strategies for catatonia: A systematic review. Gen Hosp Psychiatry. 2017;48:1-19. doi: 10.1016/j.genhosppsych.2017.06.011
- McDaniel WW, Spiegel DR, Sahota AK. Topiramate effect in catatonia: A case series. J Neuropsychiatry Clin Neurosci. 2006;18(2):234-238. doi: 10.1176/jnp.2006.18.2.234
- Muneer A. Aripiprazole in the treatment of refractory mood disorders: A case series. Clin Psychopharmacol Neurosci. 2014;12(2):157-159. doi: 10.9758/cpn.2014.12.2.157
- Nakagawa M, Yamamura S, Motomura E, Shiroyama T, Tanii H, Okada M. Combination therapy of zonisamide with aripiprazole on ECT-and benzodiazepine-resistant periodic catatonia. J Neuropsychiatry Clin Neurosci. 2012;24(3):E9. doi: 10.1176/appi.neuropsych.11080191
- Tabbane K, Halayem S, Joober R. Clozapine for the management of persistent catatonia. J Psychiatry Neurosci. 2016;41(6):E81-E82. doi: 10.1503/jpn.150352
- Dursun SM, Hallak JE, Haddad P, et al. Clozapine monotherapy for catatonic schizophrenia: Should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index? J Psychopharmacol. 2005;19(4):432-433. doi: 10.1177/0269881105053313
- England ML, Ongür D, Konopaske GT, Karmacharya R. Catatonia in psychotic patients: Clinical features and treatment response. J Neuropsychiatry Clin Neurosci. 2011;23(2):223-226. doi: 10.1176/jnp.23.2.jnp223
- Chattopadhyay S, Saha I, Dan A, Bhattacharyya K. Clozapine responsive catatonia: A series of five cases. Ind Psychiatry J. 2012;21(1):66-68. doi: 10.4103/0972-6748.110955
- Baldessarini RJ, Vázquez GH, Tondo L. Bipolar depression: A major unsolved challenge. Int J Bipolar Disord. 2020; 8(1):1. doi: 10.1186/s40345-019-0160-1
- Dranovsky A, Needleman JP, Sylvester J, VanHeertum R, Muskin PR. Progressive paranoid psychosis in a 20-year-old with central congenital hypoventilation syndrome. Pediatrics. 2014;134(3):e900-e902. doi: 10.1542/peds.2013-2740